If the manufacturer AND @mcuban are both able to make a profit off of a generic drug sold for $47 per month that normally retails for $9,600 monthly says everything about the pharmaceutical industry and outrageous #drugpricing. #smdh
https://t.co/AxGDCJ8f49 #axiosvitals
"Aducanumab priced at $56K with the efficacy of a sugar pill is taking advantage of patients, the health care system and is ruthless," one commenter said.
@JohnCendpts@endpts#stoprxgreed
https://t.co/TzwMEJg0LM
In 2020, people 50-plus accounted for nearly 95% of #COVID19 deaths. As we come to the end of this very difficult year, vaccines are offering some hope for the new year – and must be prioritized for all older Americans. Here are a few stories from early recipients:
Hospitals, health insurers and other #healthcare companies have laid off thousands in recent years in favor of having back-office work done for less money in countries like India or the Philippines. @TaraBannow@modrnhealthcr
https://t.co/dMm2PVZlHU via @modrnhealthcr
"The plaintiffs' theory of why they have standing is very weak, so the #SCOTUS justices were going to have to probe it." @nicolas_bagley @UMichLaw#AffordableCareAct#ACA#healthcare https://t.co/3eM4pttNRj
Washington's failure to put together a new stimulus package will disproportionately hurt the low-wage, front-line workers, most of them Black or Hispanic, who have borne the brunt of this entire #pandemic. @caitlinnowens@axios#healthdisparities
https://t.co/Ai7N6QDEQk #vitals